title: Simultaneous pancreas-kidney transplantation in a single center: 10-year retrospective analysis.
abstract: BACKGROUND
  Simultaneous pancreas-kidney transplantation (SPKT) is the best treatment option for diabetic patients with advanced chronic renal failure. The current study aimed to analyze the surgical indications, treatments and prognosis of SPKT.
  
  
  METHODS
  We retrospectively analyzed 40 cases of SPKT performed between December 1999 and January 2010 in our center, including the survival rate, complications and the reasons of reoperation.
  
  
  RESULTS
  Of all the 40 SPKT cases, the one-year survival rates of the recipients, kidney and pancreas transplant graft were 97.6%, 97.6% and 92.7%, while 97.6%, 91.1%, 92.7% at 3 years and 83.6%, 78.0%, 79.4% at 5 years, respectively. After SPKT, 10 patients need reoperation because of surgical complications (14 operations). The reoperation rate was 25%, including 2 patients (4 operations) with hematuria, 4 patients with abdominal hemorrhage, 2 patients (3 operations) with abdominal infection, 1 patient with pancreatic venous thrombosis, 1 patient with anastomotic leakage, and 1 patient with fistula.
  
  
  CONCLUSIONS
  Although SPKT provides a successful and effective treatment for diabetics with end-stage renal disease, how to reduce the complications of this treatment still need further effort.
authors.affiliation: Department of Transplantation, Tianjin First Central Hospital, Tianjin 300192, China.
authors.forename: Jian-Ming
authors.initials: JM
authors.lastname: Zheng
authors.forename: Wen-Li
authors.initials: WL
authors.lastname: Song
authors.forename: Jin-Peng
authors.initials: JP
authors.lastname: Tu
authors.forename: Gang
authors.initials: G
authors.lastname: Feng
authors.forename: Chun-Bai
authors.initials: CB
authors.lastname: Mo
authors.forename: Zhong-Yang
authors.initials: ZY
authors.lastname: Shen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D016035:Pancreas Transplantation; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D008795:Metronidazole